More News

27 Jul 2007 Exelixis Retains Right to Develop and Commercialize XL647
27 Jul 2007 Hydra Biosciences and Pfizer Global Research & Development
26 Jul 2007 Cell Therapeutics, Inc. (CTI) Announces Agreement to Acquire SMi; Gains Global Rights to Brostallicin, in a New Class of Cancer Killing Agents
26 Jul 2007 Merck & Co., Inc. to Acquire NovaCardia, Inc., to Boost Clinical Pipeline of Cardiovascular Drug Candidates
26 Jul 2007 BioSante Pharmaceuticals Announces Positive Resultsfor its CaP Technology for Use in Aesthetic Medicine
26 Jul 2007 Spectrum Pharmaceuticals Acquires From Indena Worldwide Rights To Ortataxel, A Phase 2 Third Generation Taxane
25 Jul 2007 Kissei Entered into an Agreement with Nuon Therapeutics, Inc on Tranilast (Product Name: Rizaben(R))
25 Jul 2007 Anika Therapeutics Receives FDA Approval for ELEVESS(TM) Product
21 Jul 2007 Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Provigil(R)
21 Jul 2007 Kirin and Terumo announce a basic agreement on a business collaboration
20 Jul 2007 Schering-Plough Announces Licensing of Acadesine, an Investigational Agent Being Studied for Prevention of Complications From Cardiac Surgery
20 Jul 2007 Glenmark purchases rights to two therapeutic antibodies from Chromos
20 Jul 2007 Severin Schwan to succeed Franz B. Humer as Chief Executive of the Roche Group at the March 2008 shareholders' meeting
20 Jul 2007 Abraxis BioScience and Biocon Limited Announce Licensing Agreement for G-CSF in North America and the European Union
20 Jul 2007 NUCRYST Pharmaceuticals receives FDA clearance
20 Jul 2007 Bone Medical Phase II Capsitonin(TM) (oral calcitonin)
19 Jul 2007 Merck Transfers Abbott Rights for Niaspan Outside the U.S.
19 Jul 2007 Arpida adds a late stage antifungal to its pipeline through acqusition of TLT Medical Ltd.
18 Jul 2007 Penwest Enters Into Collaboration Agreement With Edison Pharmaceuticals
18 Jul 2007 Ambrilia Completes Korean Licensing Partnership with Shin Poong for its Long-Acting Formulation of Octreotide
18 Jul 2007 Akorn-Strides, LLC Announces its First ANDA Approval For Keterolac Tromethamine Injection USP, 15 mg/mL and 30 mg/mL
17 Jul 2007 PreMD Signs Marketing and Distribution Agreement with AstraZeneca
17 Jul 2007 PreMD Signs Marketing and Distribution Agreement with AstraZeneca
17 Jul 2007 Findings from Four Year, Multi-Center Clinical Study on Autologous Chondrocyte Implantation Presented, Coincide with New Product Labeling
17 Jul 2007 Findings from Four Year, Multi-Center Clinical Study on Autologous Chondrocyte Implantation Presented, Coincide with New Product Labeling

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top